BTIG Maintains Buy on Staar Surgical, Raises Price Target to $53
Portfolio Pulse from Benzinga Newsdesk
BTIG analyst Ryan Zimmerman maintains a Buy rating on Staar Surgical (NASDAQ:STAA) and raises the price target from $46 to $53.
July 15, 2024 | 4:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BTIG analyst Ryan Zimmerman maintains a Buy rating on Staar Surgical and raises the price target from $46 to $53.
The raised price target and maintained Buy rating from a reputable analyst are likely to positively influence investor sentiment and drive short-term price appreciation for STAA.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100